Search Within

Brian Carl Shaffer

  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (8)
  3. Review (1)
Groups
  1. Bone Marrow Transplant (17)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Hematologic Malignancies Research (17)
  5. Hematologic Malignancies, Division of (17)
  6. GSK Faculty (15)

More Groups

People
  1. Katharine Hsu (15)
  2. Miguel-Angel Perales (8)
  3. Sergio Giralt (8)
  4. Ann Jakubowski (7)
  5. Jean-Benoit Le Luduec (7)
  6. Esperanza Papadopoulos (6)

More People

Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2020 (6)
  4. 2019 (1)
  5. 2018 (3)
  6. 2017 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (5)
  2. Blood Advances (4)
  3. Blood (3)
  4. Best Practice and Research: Clinical Haematology (1)
  5. HLA (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (6)
  3. American Society of Clinical Oncology (1)
  4. S. Karger AG (1)
  5. W.B. Saunders Co-Elsevier Inc. (1)
  6. Wiley Blackwell (1)

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SHLA-DRB1 HED is associated with improved survival and decreased relapse in patients with hematologic malignancies following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Camacho-Bydume, C.; Wang, T.; Chowell, D.; Krishna, C.; Shaffer, B. C.; Marsh, S.; Paczesny, S.; Gadalla, S. M.; He, M.; Bolon, Y. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Emergence of human CMV-induced NKG2C(+) NK cells is associated with CD8(+) T-cell recovery after allogeneic HCT
    Journal Article

    van der Ploeg, K.; Sottile, R.; Kontopoulos, T.; Shaffer, B. C.; Papanicolaou, G. A.; Maloy, M. A.; Cho, C.; Robinson, K. S.; Perales, M. A.; Jean-Benoît, L. L.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML
    Journal Article

    Shaffer, B. C.; Le Luduec, J. B.; Park, S.; Devlin, S.; Archer, A.; Davis, E.; Cooper, C.; Nhaissi, M.; Suri, B.; Wells, D.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Selection of allogeneic hematopoietic cell transplant donors to optimize natural killer cell alloreactivity
    Review

    Shaffer, B. C.; Hsu, K. C.
    Seminars in Hematology (2020)

    Fulltext@MSK | Save
  • High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
    Journal Article

    Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Prognostic factors for postrelapse survival after ex vivo CD34(+)-selected (T cell-depleted) allogeneic hematopoietic cell transplantation in multiple myeloma
    Journal Article

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Scordo, M.; Ruiz, J. D.; Bryant, A.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation
    Journal Article

    van der Ploeg, K.; Le Luduec, J. B.; Stevenson, P. A.; Park, S.; Gooley, T. A.; Petersdorf, E. W.; Shaffer, B. C.; Hsu, K. C.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia
    Meeting Abstract

    Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Time to relapse and the patterns of relapse are prognostic for post-relapse survival after CD34(+)-selected allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Meeting Abstract

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Ruiz, J. D.; Bryant, A.; Chung, D. J.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save